Duncan McGregor
Vice President Discovery @Abilita Therapeutics, Inc
Signup · Get unlimited contacts
WORK HISTORY
Vice President Discovery @Abilita Therapeutics, Inc
EDUCATION
University of Aberdeen
Genetics
SKILLS
ABOUT DUNCAN MCGREGOR
I have extensive antibody and protein engineering experience in the biotechnology industry stretching back to the early nineties from bench level scientist to senior management and board level. Cyclogenix focuses on discovering and developing immuno-oncology assets using its bispecific cylobody platform. Until starting Cyclogenix I occupied the CSO role at Haptogen Ltd for the year prior to its acquisition by Wyeth. I was also on the board of Haptogen from 20••••07. The company owned rights to a proprietary peptide & antibody phage display system (DBDx®), that I invented while working as Principal Research Scientist at Rowett Research Services Ltd in Aberdeen. Previously, I was VP Research & Development at Isogenica Ltd, a peptide display technology company based in Cambridge, UK where I played a key role in inventing and commercializing Isogenica’s in vitro CIS display technology platform. Previously, I was a project leader at Scotgen Biopharmaceuticals Ltd, responsible for successfully establishing antibody and peptide phage display technologies.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.